[Therapeutic potential of DPP-IV inhibitor for the treatment of Type 2 diabetes].
Yasuda
Nobuyuki
N
n-yasuda@hhc.eisai.co.jp
Yamazaki
Kazuto
K
Inoue
Takashi
T
Nagakura
Tadashi
T
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D018819:Dipeptidyl Peptidase 4 / Q000032:analysis; D005934:Glucagon / Q000378:metabolism; D052216:Glucagon-Like Peptide 1; D006801:Humans; D009570:Nitriles / Q000627:therapeutic use*; D010446:Peptide Fragments / Q000378:metabolism; D011498:Protein Precursors / Q000378:metabolism; D011759:Pyrrolidines / Q000627:therapeutic use*
C121834:1-(((2-((5-cyanopyridin-2-yl)amino)ethyl)amino)acetyl)-2-cyano-(S)-pyrrolidine; D009570:Nitriles; D010446:Peptide Fragments; D011498:Protein Precursors; D011759:Pyrrolidines; D052216:Glucagon-Like Peptide 1; D005934:Glucagon; D018819:Dipeptidyl Peptidase 4